Fontan Geometry and Hemodynamics Are Associated With Quality of Life in Adolescents and Young Adults.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
09 2022
Historique:
received: 08 03 2021
revised: 23 11 2021
accepted: 05 01 2022
pubmed: 6 2 2022
medline: 1 9 2022
entrez: 5 2 2022
Statut: ppublish

Résumé

Despite favorable short-term outcomes, Fontan palliation is associated with comorbidities and diminished quality of life (QOL) in the years after completion. We hypothesized that poor Fontan hemodynamics and ventricular function are associated with worse QOL. This was a single-center study of Fontan survivors aged more than 12 years. Subjects completed a cardiac magnetic resonance scan and QOL questionnaire. Cardiac magnetic resonance-derived variables included Fontan geometry, and hemodynamics. Computational fluid dynamics simulations quantified power loss, pressure drop, and total cavopulmonary connection resistance across the Fontan. Quality of life was assessed by completion of the Pediatric Quality of Life Inventory. Longitudinal and cross-sectional comparisons were made between cardiac magnetic resonance and computational fluid dynamics parameters with patient-reported QOL. We studied 77 Fontan patients, median age 19.7 years (interquartile range, 17.1 to 23.6), median time from Fontan completion 16 years (interquartile range, 13 to 20). Longitudinal data were available for 48 patients; median time between cardiac magnetic resonance and QOL was 8.1 years (interquartile range, 7 to 9.4). Median patient-reported Pediatric Quality of Life Inventory total score was 80 (interquartile range, 67.4 to 88). Greater power loss and smaller left pulmonary artery diameter at baseline were associated with worse QOL at follow-up. Greater pressure drop was associated with worse QOL at the same time point. For Fontan survivors, measures of computational fluid dynamics hemodynamics and geometry are associated with worse QOL. Interventional strategies targeted at optimizing the Fontan may improve QOL.

Sections du résumé

BACKGROUND
Despite favorable short-term outcomes, Fontan palliation is associated with comorbidities and diminished quality of life (QOL) in the years after completion. We hypothesized that poor Fontan hemodynamics and ventricular function are associated with worse QOL.
METHODS
This was a single-center study of Fontan survivors aged more than 12 years. Subjects completed a cardiac magnetic resonance scan and QOL questionnaire. Cardiac magnetic resonance-derived variables included Fontan geometry, and hemodynamics. Computational fluid dynamics simulations quantified power loss, pressure drop, and total cavopulmonary connection resistance across the Fontan. Quality of life was assessed by completion of the Pediatric Quality of Life Inventory. Longitudinal and cross-sectional comparisons were made between cardiac magnetic resonance and computational fluid dynamics parameters with patient-reported QOL.
RESULTS
We studied 77 Fontan patients, median age 19.7 years (interquartile range, 17.1 to 23.6), median time from Fontan completion 16 years (interquartile range, 13 to 20). Longitudinal data were available for 48 patients; median time between cardiac magnetic resonance and QOL was 8.1 years (interquartile range, 7 to 9.4). Median patient-reported Pediatric Quality of Life Inventory total score was 80 (interquartile range, 67.4 to 88). Greater power loss and smaller left pulmonary artery diameter at baseline were associated with worse QOL at follow-up. Greater pressure drop was associated with worse QOL at the same time point.
CONCLUSIONS
For Fontan survivors, measures of computational fluid dynamics hemodynamics and geometry are associated with worse QOL. Interventional strategies targeted at optimizing the Fontan may improve QOL.

Identifiants

pubmed: 35120878
pii: S0003-4975(22)00140-0
doi: 10.1016/j.athoracsur.2022.01.017
pmc: PMC9528566
mid: NIHMS1804348
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

841-847

Subventions

Organisme : NHLBI NIH HHS
ID : K01 HL125521
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL067622
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL098252
Pays : United States

Informations de copyright

Copyright © 2022 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Références

J Thorac Cardiovasc Surg. 2014 Oct;148(4):1481-9
pubmed: 24507891
Med Care. 2001 Aug;39(8):800-12
pubmed: 11468499
J Magn Reson Imaging. 2009 Jan;29(1):155-65
pubmed: 19097101
Heart. 2017 Nov;103(22):1806-1812
pubmed: 28522658
Heart. 2015 Jan;101(2):139-43
pubmed: 25184826
J Thorac Cardiovasc Surg. 2013 Feb;145(2):482-488.e2
pubmed: 22507845
Ann Thorac Surg. 2015 Mar;99(3):911-7
pubmed: 25620596
J Am Coll Cardiol. 2018 Mar 6;71(9):1009-1017
pubmed: 29495980
Cardiol Young. 2017 Mar;27(2):333-343
pubmed: 27225489
Thorax. 1971 May;26(3):240-8
pubmed: 5089489
J Am Coll Cardiol. 2008 Jul 8;52(2):99-107
pubmed: 18598887
J Pediatr. 2019 Feb;205:21-28.e2
pubmed: 30366775
World J Pediatr Congenit Heart Surg. 2019 Nov;10(6):750-758
pubmed: 31658880
Int J Cardiol. 2013 Oct 9;168(4):3230-5
pubmed: 23632112
Pediatrics. 2010 Sep;126(3):498-508
pubmed: 20805147
J Pediatr. 2016 Mar;170:166-72.e1
pubmed: 26685073
J Am Coll Cardiol. 2015 Oct 13;66(15):1700-10
pubmed: 26449141
Ambul Pediatr. 2004 Jul-Aug;4(4 Suppl):358-64
pubmed: 15264947
Pediatr Cardiol. 2007 Jul-Aug;28(4):255-62
pubmed: 17486393
Ann Biomed Eng. 2018 Mar;46(3):404-416
pubmed: 29094292
J Thorac Cardiovasc Surg. 1995 Apr;109(4):654-62
pubmed: 7715212
Circ Arrhythm Electrophysiol. 2012 Dec;5(6):1064-72
pubmed: 23212181
J Pediatr. 2016 Jun;173:154-9
pubmed: 26875011
Circulation. 1994 Jan;89(1):243-51
pubmed: 8281653
J Pediatr. 2017 Oct;189:162-168
pubmed: 28734657
J Am Heart Assoc. 2018 Oct 2;7(19):e009145
pubmed: 30371305
J Cardiovasc Nurs. 2012 Nov-Dec;27(6):539-46
pubmed: 21912272
Cardiol Young. 2016 Mar;26(3):459-68
pubmed: 25906441
J Am Coll Cardiol. 2017 Jun 6;69(22):2735-2744
pubmed: 28571639
World J Pediatr Congenit Heart Surg. 2015 Oct;6(4):630-9
pubmed: 26467877
Ambul Pediatr. 2003 Nov-Dec;3(6):329-41
pubmed: 14616041
J Pediatr. 2014 Apr;164(4):781-788.e1
pubmed: 24412135
Qual Life Res. 2008 May;17(4):613-26
pubmed: 18347927

Auteurs

Laura Mercer-Rosa (L)

Division of Cardiology, Department of Pediatrics, Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: mercerrosal@chop.edu.

Mark A Fogel (MA)

Division of Cardiology, Department of Pediatrics, Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Zhenglun Alan Wei (ZA)

Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Emory University, Atlanta, Georgia.

Phillip M Trusty (PM)

Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Emory University, Atlanta, Georgia.

Michael Tree (M)

Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Emory University, Atlanta, Georgia.

Elaine Tang (E)

Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Emory University, Atlanta, Georgia.

Maria Restrepo (M)

Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Emory University, Atlanta, Georgia.

Kevin K Whitehead (KK)

Division of Cardiology, Department of Pediatrics, Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Amy Cassedy (A)

Division of Biostatistics and Epidemiology, Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.

Stephen M Paridon (SM)

Division of Cardiology, Department of Pediatrics, Children's Hospital of Philadelphia and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Ajit Yoganathan (A)

Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Emory University, Atlanta, Georgia; School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia.

Bradley S Marino (BS)

Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH